Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Coronavirus Disease 2019 Vaccination Trends: Findings from Surveillance Conducted at First Antenatal Care Visits in Kenya, Nigeria, Malawi, Mozambique, Uganda, and Zambia, 2021–2022
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.24-0826 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Victoria Seffren und 16 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Branch, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease C…. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Mass Vaccination. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Estimates of exposure to coronavirus disease 2019 (COVID-19) on the African continent are limited, constrained by availability of testing and case report data. To improve understanding of COVID-19 burden, monthly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveillance was implemented at first antenatal care visits (ANC1) across six sub-Saharan African countries (Kenya, Malawi, Mozambique, Nigeria, Uganda, and Zambia). A standardized questionnaire, including COVID-19 vaccination history, was administered, and a blood sample was collected. Serology was conducted with two assays: in Nigeria, a multiplex bead-based assay targetting spike protein, receptor binding domain (RBD) 591, and nucleocapsid (N) protein and in all other countries, a SARS-CoV-2 human IgG antibody test including RBD, N protein, and hybrid RBD-N. The largest monthly change in seropositivity was between December 2021 and January 2022 for five countries (Kenya: 33.2–70.3%, Malawi: 28.3–59.6%, Mozambique: 29.3–72.8%, Nigeria: 52.4–77.4%, Uganda: 55.7–80.6%), coinciding with the Omicron wave. Aside from Mozambique, there was an increase in the proportion of women reporting COVID-19 vaccination beginning in January 2022, with highest vaccination rates between April and August 2022. Relatedly, there was an increase in the proportion vaccinated among those with detectable SARS-CoV-2 antibodies. Adenoviral vector accounted for at least half of the vaccines reported in all countries. If pregnant women are not differentially infected, ANC1 can be leveraged for serosurveillance during a pandemic. Monthly seroprevalence estimates alongside vaccination rates can provide evidence for changes in protective immunity in response to case waves and the introduction of protective measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Malaria Branch, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
- CDC Nigeria, Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Abuja, Nigeria.
- APIN Public Health Initiatives, Nigeria, Abuja, Nigeria.
- PATH, Lusaka, Zambia.
- Adult Centre of Excellence, University Teaching Hospital, Lusaka, Zambia.
- Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.
Zitieren
APA
Seffren, V., Yadav, R., Iriemenam, N. C., Ajayi, O., Ogunsola, O., Mulube, C., Chilambe, F. B., Soko, M., Ogollah, F., Chomba, M., Seda, B., Cossa-Moiane, I., Langa, Z., Oboth, P., Kwizera, R., Rogier, E., & Gutman, J. R. (2025). Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Coronavirus Disease 2019 Vaccination Trends: Findings from Surveillance Conducted at First Antenatal Care Visits in Kenya, Nigeria, Malawi, Mozambique, Uganda, and Zambia, 2021–2022. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.24-0826
Vancouver
Seffren V, Yadav R, Iriemenam NC, Ajayi O, Ogunsola O, Mulube C, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Coronavirus Disease 2019 Vaccination Trends: Findings from Surveillance Conducted at First Antenatal Care Visits in Kenya, Nigeria, Malawi, Mozambique, Uganda, and Zambia, 2021–2022. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.24-0826
BibTeX
@article{Seffren2025,
author = {Seffren, Victoria and Yadav, Ruchi and Iriemenam, Nnaemeka C and Ajayi, Oluseye and Ogunsola, Olabanjo and Mulube, Conceptor and Chilambe, Felix Bwalya and Soko, Monica and Ogollah, Francis and Chomba, Miriam and Seda, Brian and Cossa-Moiane, Idalécia and Langa, Zainabo and Oboth, Paul and Kwizera, Richard and Rogier, Eric and Gutman, Julie R},
title = {Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Coronavirus Disease 2019 Vaccination Trends: Findings from Surveillance Conducted at First Antenatal Care Visits in Kenya, Nigeria, Malawi, Mozambique, Uganda, and Zambia, 2021–2022},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.24-0826}
}
EUVIMED